OTC : AVEFF

Avecho Biotechnology Limited

$0.0045 USD

$0 (0.0%)

Volume
300K
Average Volume
260K
Market Capitalization
$13.35M
P/E Ratio
-15.71
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.95
Company Overview

OTC

Paul Gavin

Biotechnology

Healthcare

AVEFF

15

AU

USD

https://avecho.com.au

61 3 9002 5000

N/A

N/A

Liquidity Metrics

0.01

9.95

9.94

6.58

0.00

Sales & Valuation

$1.24M

52.74

48.32

-56.13

0.00

Profitability

$0.0013

-$4.41M

-248.73%

-518.07%

-258.19%

-43.32%

P/E Metrics

-15.71

0.16

0.16

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

-48.84

4/9

$6.34M

$7.1M

$5.54M

-$8.28M

Key Metrics (TTM)

$57.66M

46.58

-9.83

9.95

-258.19%

-64.50%

-4.28%

-1.87%

578 days

Company Executives
Name Title
Naomi Lawrie Company Secretary
Roksan Libinaki Chief Operating Officer
Paul Gavin Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About Avecho Biotechnology Limited (OTC:AVEFF) Stock

Avecho Biotechnology Limited is an Australian-based firm specializing in the development, production, and sale of various products. Central to its operations is the proprietary and patented Targeted Penetration Matrix (TPM) drug delivery system, which the company leverages across the pharmaceutical, skincare, animal health, and nutrition industries. Its product portfolio includes TPM and Vital ET, which are incorporated into drug delivery systems and cosmetic formulations. The company is also actively engaged in the development of TPM/Oxymorphone and TPM/Oxycodone. For human health, Avecho's offerings facilitate drug administration through diverse methods such as gels, injectables, and transdermal patches. Additionally, it provides non-antibiotic feed additives aimed at enhancing the healt ... h and feed efficiency of livestock. Avecho demonstrates its commitment to research through a collaboration with the Lambert Initiative at the University of Sydney, jointly conducting a study to explore the potential of topically applied cannabidiol for alleviating osteoarthritis symptoms. The company's reach extends internationally, serving clients in Australia, Switzerland, India, and other global markets. Founded in 1992, the company was previously known as Phosphagenics Limited before adopting the name Avecho Biotechnology Limited in May 2019. Its headquarters are situated in Clayton, Australia.

Avecho completes treatment phase for Phase III insomnia trial interim analysis

2026-05-21 07:53:00

Avecho Biotechnology Ltd (ASX:AVE, OTC:AVEFF, FRA:OEZ) has completed the treatment phase for the final patient required for the planned interim analysis of...

Frequently Asked Questions

What is the current Avecho Biotechnology Limited (AVEFF) stock price?

Avecho Biotechnology Limited(OTC:AVEFF) stock price is $0.0045 in the last trading session. During the trading session, AVEFF stock reached the peak price of $0.0045 while $0.003 was the lowest point it dropped to. The percentage change in AVEFF stock occurred in the recent session was 0.0% while the dollar amount for the price change in AVEFF stock was $0.

AVEFF's industry and sector of operation?

The OTC listed AVEFF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of AVEFF?

Naomi Lawrie | Company Secretary
Roksan Libinaki | Chief Operating Officer
Paul Gavin | Chief Executive Officer
|
|

How many employees does AVEFF have?

Number of AVEFF employees currently stands at 15. AVEFF operates from 2A Westall Road, Clayton, VIC 3168, AU.

Link for AVEFF official website?

Official Website of AVEFF is: https://avecho.com.au

How do I contact AVEFF?

AVEFF could be contacted at phone #61 3 9002 5000 and can also be accessed through its website. AVEFF operates from 2A Westall Road, Clayton, VIC 3168, AU.

How many shares of AVEFF are traded daily?

The average number of AVEFF shares traded daily for last 3 months was 260K.

What is the market cap of AVEFF currently?

The market value of AVEFF currently stands at $13.35M with its latest stock price at $0.0045